Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1976 1
1985 1
1986 1
1987 1
1989 1
1996 1
1999 4
2000 2
2001 1
2003 5
2004 3
2005 1
2006 1
2007 1
2008 1
2010 1
2011 1
2012 1
2013 2
2014 1
2015 1
2016 2
2019 1
2021 2
2022 1
2023 5
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Proteomic and phosphoproteomic landscapes of acute myeloid leukemia.
Kramer MH, Zhang Q, Sprung R, Day RB, Erdmann-Gilmore P, Li Y, Xu Z, Helton NM, George DR, Mi Y, Westervelt P, Payton JE, Ramakrishnan SM, Miller CA, Link DC, DiPersio JF, Walter MJ, Townsend RR, Ley TJ. Kramer MH, et al. Among authors: day rb. Blood. 2022 Sep 29;140(13):1533-1548. doi: 10.1182/blood.2022016033. Blood. 2022. PMID: 35895896 Free PMC article.
Genomic landscape of TP53-mutated myeloid malignancies.
Abel HJ, Oetjen KA, Miller CA, Ramakrishnan SM, Day RB, Helton NM, Fronick CC, Fulton RS, Heath SE, Tarnawsky SP, Nonavinkere Srivatsan S, Duncavage EJ, Schroeder MC, Payton JE, Spencer DH, Walter MJ, Westervelt P, DiPersio JF, Ley TJ, Link DC. Abel HJ, et al. Among authors: day rb. Blood Adv. 2023 Aug 22;7(16):4586-4598. doi: 10.1182/bloodadvances.2023010156. Blood Adv. 2023. PMID: 37339484 Free PMC article.
Genomic landscape of TP53 -mutated myeloid malignancies.
Abel HJ, Oetjen KA, Miller CA, Ramakrishnan SM, Day RB, Helton NM, Fronick CC, Fulton RS, Heath SE, Tarnawsky SP, Srivatsan SN, Duncavage EJ, Schroeder MC, Payton JE, Spencer DH, Walter MJ, Westervelt P, DiPersio JF, Ley TJ, Link DC. Abel HJ, et al. Among authors: day rb. medRxiv [Preprint]. 2023 Jan 11:2023.01.10.23284322. doi: 10.1101/2023.01.10.23284322. medRxiv. 2023. Update in: Blood Adv. 2023 Aug 22;7(16):4586-4598. doi: 10.1182/bloodadvances.2023010156 PMID: 36711871 Free PMC article. Updated. Preprint.
Description of a novel subtype of acute myeloid leukemia defined by recurrent CBFB insertions.
Ryland GL, Umeda M, Holmfeldt L, Lehmann S, Herlin MK, Ma J, Khanlari M, Rubnitz JE, Ries RE, Kosasih HJ, Ekert PG, Goh HN, Tiong IS, Grimmond SM, Haferlach C, Day RB, Ley TJ, Meshinchi S, Ma X, Blombery P, Klco JM. Ryland GL, et al. Among authors: day rb. Blood. 2023 Feb 16;141(7):800-805. doi: 10.1182/blood.2022017874. Blood. 2023. PMID: 36179268 Free PMC article. No abstract available.
Tumor suppressor function of Gata2 in acute promyelocytic leukemia.
Katerndahl CDS, Rogers ORS, Day RB, Cai MA, Rooney TP, Helton NM, Hoock M, Ramakrishnan SM, Nonavinkere Srivatsan S, Wartman LD, Miller CA, Ley TJ. Katerndahl CDS, et al. Among authors: day rb. Blood. 2021 Sep 30;138(13):1148-1161. doi: 10.1182/blood.2021011758. Blood. 2021. PMID: 34125173 Free PMC article.
Aminoglycoside dosing in pediatric patients.
Carlstedt BC, Uaamnuichai M, Day RB, Bowman L, Brater DC. Carlstedt BC, et al. Among authors: day rb. Ther Drug Monit. 1989;11(1):38-43. doi: 10.1097/00007691-198901000-00008. Ther Drug Monit. 1989. PMID: 2911852
44 results